86 results
8-K
EX-99.2
hdrefwm8srzu9yq hmln
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
8-K
EX-99.1
awdz2 qqmbnz
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
8-K
EX-99.1
nf2hitimm17s
9 Feb 24
Index to Consolidated Financial Statements
4:01pm
8-K
k44dhldv t4cs
9 Feb 24
Index to Consolidated Financial Statements
4:01pm
8-K
EX-10.1
u21d6 cdzt6sxrhr1
22 Dec 23
Entry into a Material Definitive Agreement
4:53pm
424B5
nw4 czsq9nolmu2jjn
22 Dec 23
Prospectus supplement for primary offering
4:51pm
8-K
EX-10.1
7uagks5ibbd
5 Sep 23
Invivyd Appoints William Duke As Chief Financial Officer
7:05am
DEF 14A
kcxi1r18icdo
10 Apr 23
Definitive proxy
4:07pm